FR2279416B1 - - Google Patents

Info

Publication number
FR2279416B1
FR2279416B1 FR7522490A FR7522490A FR2279416B1 FR 2279416 B1 FR2279416 B1 FR 2279416B1 FR 7522490 A FR7522490 A FR 7522490A FR 7522490 A FR7522490 A FR 7522490A FR 2279416 B1 FR2279416 B1 FR 2279416B1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR7522490A
Other versions
FR2279416A1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Toyama Chemical Co Ltd
Original Assignee
Toyama Chemical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP49083887A external-priority patent/JPS5112915A/ja
Priority claimed from JP50060251A external-priority patent/JPS51136888A/ja
Application filed by Toyama Chemical Co Ltd filed Critical Toyama Chemical Co Ltd
Publication of FR2279416A1 publication Critical patent/FR2279416A1/fr
Application granted granted Critical
Publication of FR2279416B1 publication Critical patent/FR2279416B1/fr
Granted legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/21Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Pseudomonadaceae (F)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00Chemistry: molecular biology and microbiology
    • Y10S435/8215Microorganisms
    • Y10S435/822Microorganisms using bacteria or actinomycetales
    • Y10S435/874Pseudomonas
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/82Proteins from microorganisms
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/82Proteins from microorganisms
    • Y10S530/825Bacteria

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
FR7522490A 1974-07-22 1975-07-18 Nouveau polypeptide a activite anti-tumorale Granted FR2279416A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP49083887A JPS5112915A (fr) 1974-07-22 1974-07-22
JP50060251A JPS51136888A (en) 1975-05-22 1975-05-22 Process for preparing carcinostatic substance

Publications (2)

Publication Number Publication Date
FR2279416A1 FR2279416A1 (fr) 1976-02-20
FR2279416B1 true FR2279416B1 (fr) 1978-11-10

Family

ID=26401323

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7522490A Granted FR2279416A1 (fr) 1974-07-22 1975-07-18 Nouveau polypeptide a activite anti-tumorale

Country Status (6)

Country Link
US (1) US4016260A (fr)
CH (1) CH606429A5 (fr)
DE (1) DE2532589A1 (fr)
FR (1) FR2279416A1 (fr)
GB (1) GB1475624A (fr)
NL (1) NL7508663A (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9352020B2 (en) 2013-03-15 2016-05-31 Mead Johnson Nutrition Company Reducing proinflammatory response
US9345727B2 (en) 2013-03-15 2016-05-24 Mead Johnson Nutrition Company Nutritional compositions containing a peptide component and uses thereof
US8889633B2 (en) 2013-03-15 2014-11-18 Mead Johnson Nutrition Company Nutritional compositions containing a peptide component with anti-inflammatory properties and uses thereof
US9138455B2 (en) 2013-03-15 2015-09-22 Mead Johnson Nutrition Company Activating adiponectin by casein hydrolysate
US9345741B2 (en) 2013-03-15 2016-05-24 Mead Johnson Nutrition Company Nutritional composition containing a peptide component with adiponectin simulating properties and uses thereof
US9289461B2 (en) 2013-03-15 2016-03-22 Mead Johnson Nutrition Company Reducing the risk of autoimmune disease

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3705237A (en) * 1970-07-17 1972-12-05 Rolland Sa A Antibiotic substance and process for the extraction of such an antibiotic substance from a new strain of pseudomonas

Also Published As

Publication number Publication date
FR2279416A1 (fr) 1976-02-20
NL7508663A (nl) 1976-01-26
DE2532589A1 (de) 1976-05-26
CH606429A5 (fr) 1978-10-31
GB1475624A (en) 1977-06-01
US4016260A (en) 1977-04-05

Similar Documents

Publication Publication Date Title
FR2272930A1 (fr)
FR2266458A1 (fr)
JPS50120132A (fr)
FI77174A (fr)
CS172099B1 (fr)
JPS50139762U (fr)
AU7034374A (fr)
CH583320A5 (fr)
CH583329B5 (fr)
CH578250A5 (fr)
CH578470A5 (fr)
BG22107A1 (fr)
CH578724A5 (fr)
CH578938A5 (fr)
CH579307A5 (fr)
CH580484A5 (fr)
CH580825A5 (fr)
CH580892A5 (fr)
CH581259A5 (fr)
CH581366A5 (fr)
CH568044A5 (fr)
CH581767A5 (fr)
CH561530A5 (fr)
CH581879A5 (fr)
CH583799A5 (fr)

Legal Events

Date Code Title Description
ST Notification of lapse